European Archives - Page 442 of 1636 - European Medical Journal

Light Therapy and Tranexamic Acid Reduce Facial Redness

Discover a study highlighting the improved effectiveness of combining light-based therapy with tranexamic acid for treating facial redness.

Spotlight on CIDP

Exploration of key data on chronic inflammatory demyelinating polyneuropathy (CIDP) presented at EHA 2025. Post-hoc analysis of the ADHERE…

EMJ's latest Neurology journal

Discover everything you need to know from EAN 2025 and beyond in our latest publication, including the largest interventional trial in…

Distinct Resting-State EEG Biomarkers Predict Amyloid Status and Alzheimer’s Conversion

Resting-state EEG (RS-EEG) has emerged as a non-invasive, low-cost tool for Alzheimer’s disease (AD) diagnosis and stratification…

EMJ Neurology 13.1 2025

Inside this issue, you will find a variety of content, including our independent review of the 11th Congress of the EAN, alongside exclusive..

Review of the 11ᵗʰ Congress of the European Academy of Neurology (EAN)

THE SUMMER solstice this year was celebrated by many neurologists in the charming city of Helsinki, Finland, as they came together for EAN…

How Clinicians Can Encourage People with Multiple Sclerosis

Multiple sclerosis (MS) is a complex, lifelong neurological condition that presents with unpredictable symptoms, progressive disability…

The New McDonald Criteria: Faster and Improved Diagnosis of Multiple Sclerosis

THE 2024 REVISED McDonald Criteria for multiple sclerosis (MS) diagnosis were explained in detail during a joint session between the EAN…

Third-Party Reports of SUDEP in Adults and Older Adolescents

Sudden unexpected death in epilepsy (SUDEP) is the most significant complication of epilepsy, with an incidence of 1.2 per 1,000…

EAN 2025: What’s New in Neurology Guidelines?

With a mission to standardise and elevate the quality of neurological care across Europe, EAN 2025 introduced updates and new guidance in…